Ahmed, M.Z.; Khan, U.A.; Haye, A.; Agarwal, N.B.; Alhakamy, N.A.; Alhadrami, H.A.; Warsi, M.H.; Jain, G.K.
Liquid Crystalline Nanoparticles for Nasal Delivery of Rosuvastatin: Implications on Therapeutic Efficacy in Management of Epilepsy. Pharmaceuticals 2020, 13, 356.
https://doi.org/10.3390/ph13110356
AMA Style
Ahmed MZ, Khan UA, Haye A, Agarwal NB, Alhakamy NA, Alhadrami HA, Warsi MH, Jain GK.
Liquid Crystalline Nanoparticles for Nasal Delivery of Rosuvastatin: Implications on Therapeutic Efficacy in Management of Epilepsy. Pharmaceuticals. 2020; 13(11):356.
https://doi.org/10.3390/ph13110356
Chicago/Turabian Style
Ahmed, Mohammad Zubair, Urooj A. Khan, Abdul Haye, Nidhi B. Agarwal, Nabil A. Alhakamy, Hani A. Alhadrami, Musarrat Husain Warsi, and Gaurav K. Jain.
2020. "Liquid Crystalline Nanoparticles for Nasal Delivery of Rosuvastatin: Implications on Therapeutic Efficacy in Management of Epilepsy" Pharmaceuticals 13, no. 11: 356.
https://doi.org/10.3390/ph13110356
APA Style
Ahmed, M. Z., Khan, U. A., Haye, A., Agarwal, N. B., Alhakamy, N. A., Alhadrami, H. A., Warsi, M. H., & Jain, G. K.
(2020). Liquid Crystalline Nanoparticles for Nasal Delivery of Rosuvastatin: Implications on Therapeutic Efficacy in Management of Epilepsy. Pharmaceuticals, 13(11), 356.
https://doi.org/10.3390/ph13110356
